Orai1 Facilitates Angiogenesis After Myocardial Infarction Through Notch1 Signaling Pathway.
Saved in:
| Title: | Orai1 Facilitates Angiogenesis After Myocardial Infarction Through Notch1 Signaling Pathway. |
|---|---|
| Authors: | Galeano-Otero I; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.).; Reprogramming Tumor Activity and Associated Microenvironment, Bordeaux Institute of Oncology-UMR1312 Inserm, Université of Bordeaux, Pessac, France (I.G.-O., G.S., A.-M.K.)., Dominguez-Liste B; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.)., Asprón C; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.)., Fernández-Chacón M; Faculty of Health Sciences, Loyola Biomedical Research Group, Department of Health and Biomedical Sciences, Universidad Loyola Andalucía, Seville, Spain (M.F.-C.)., Escacena-Izquierdo L; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.)., Del Toro R; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.)., Rojas-Torres M; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, Spain (M.R.-T., M.C.D.-R.).; Biomedical Research and Innovation Institute of Cadiz, Spain (M.R.-T., M.C.D.-R.)., Durán-Ruiz MC; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, Spain (M.R.-T., M.C.D.-R.).; Biomedical Research and Innovation Institute of Cadiz, Spain (M.R.-T., M.C.D.-R.)., Siegfried G; Reprogramming Tumor Activity and Associated Microenvironment, Bordeaux Institute of Oncology-UMR1312 Inserm, Université of Bordeaux, Pessac, France (I.G.-O., G.S., A.-M.K.)., Ordóñez-Fernández A; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.)., Khatib AM; Reprogramming Tumor Activity and Associated Microenvironment, Bordeaux Institute of Oncology-UMR1312 Inserm, Université of Bordeaux, Pessac, France (I.G.-O., G.S., A.-M.K.)., Rosado JA; Department of Physiology, Institute of Molecular Pathology Biomarkers, University of Extremadura, Caceres, Spain (J.A.R.)., Smani T; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.). |
| Source: | Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2026 Jun; Vol. 46 (6), pp. e324231. Date of Electronic Publication: 2026 Apr 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505803 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4636 (Electronic) Linking ISSN: 10795642 NLM ISO Abbreviation: Arterioscler Thromb Vasc Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41988713 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Orai1 Facilitates Angiogenesis After Myocardial Infarction Through Notch1 Signaling Pathway. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Galeano-Otero+I%22">Galeano-Otero I</searchLink>; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.).; Reprogramming Tumor Activity and Associated Microenvironment, Bordeaux Institute of Oncology-UMR1312 Inserm, Université of Bordeaux, Pessac, France (I.G.-O., G.S., A.-M.K.).<br /><searchLink fieldCode="AU" term="%22Dominguez-Liste+B%22">Dominguez-Liste B</searchLink>; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.).<br /><searchLink fieldCode="AU" term="%22Asprón+C%22">Asprón C</searchLink>; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.).<br /><searchLink fieldCode="AU" term="%22Fernández-Chacón+M%22">Fernández-Chacón M</searchLink>; Faculty of Health Sciences, Loyola Biomedical Research Group, Department of Health and Biomedical Sciences, Universidad Loyola Andalucía, Seville, Spain (M.F.-C.).<br /><searchLink fieldCode="AU" term="%22Escacena-Izquierdo+L%22">Escacena-Izquierdo L</searchLink>; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.).<br /><searchLink fieldCode="AU" term="%22Del+Toro+R%22">Del Toro R</searchLink>; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.).<br /><searchLink fieldCode="AU" term="%22Rojas-Torres+M%22">Rojas-Torres M</searchLink>; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, Spain (M.R.-T., M.C.D.-R.).; Biomedical Research and Innovation Institute of Cadiz, Spain (M.R.-T., M.C.D.-R.).<br /><searchLink fieldCode="AU" term="%22Durán-Ruiz+MC%22">Durán-Ruiz MC</searchLink>; Biomedicine, Biotechnology and Public Health Department, University of Cadiz, Spain (M.R.-T., M.C.D.-R.).; Biomedical Research and Innovation Institute of Cadiz, Spain (M.R.-T., M.C.D.-R.).<br /><searchLink fieldCode="AU" term="%22Siegfried+G%22">Siegfried G</searchLink>; Reprogramming Tumor Activity and Associated Microenvironment, Bordeaux Institute of Oncology-UMR1312 Inserm, Université of Bordeaux, Pessac, France (I.G.-O., G.S., A.-M.K.).<br /><searchLink fieldCode="AU" term="%22Ordóñez-Fernández+A%22">Ordóñez-Fernández A</searchLink>; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).<br /><searchLink fieldCode="AU" term="%22Khatib+AM%22">Khatib AM</searchLink>; Reprogramming Tumor Activity and Associated Microenvironment, Bordeaux Institute of Oncology-UMR1312 Inserm, Université of Bordeaux, Pessac, France (I.G.-O., G.S., A.-M.K.).<br /><searchLink fieldCode="AU" term="%22Rosado+JA%22">Rosado JA</searchLink>; Department of Physiology, Institute of Molecular Pathology Biomarkers, University of Extremadura, Caceres, Spain (J.A.R.).<br /><searchLink fieldCode="AU" term="%22Smani+T%22">Smani T</searchLink>; Group of Cardiovascular Pathophysiology, Institute of Biomedicine of Seville, University Hospital of Virgen del Rocio/University of Seville/CSIC, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., A.O.-F., T.S.).; Faculty of Medicine, Department of Medical Physiology and Biophysics, University of Seville, Spain (I.G.-O., B.D.-L., C.A., L.E.-I., R.D.T., T.S.). – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229505803%22">Arteriosclerosis, thrombosis, and vascular biology</searchLink> [Arterioscler Thromb Vasc Biol] 2026 Jun; Vol. 46 (6), pp. e324231. <i>Date of Electronic Publication: </i>2026 Apr 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9505803 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1524-4636 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210795642%22">10795642 </searchLink><i>NLM ISO Abbreviation: </i>Arterioscler Thromb Vasc Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41988713 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1161/ATVBAHA.125.324231 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e324231 Titles: – TitleFull: Orai1 Facilitates Angiogenesis After Myocardial Infarction Through Notch1 Signaling Pathway. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Galeano-Otero I – PersonEntity: Name: NameFull: Dominguez-Liste B – PersonEntity: Name: NameFull: Asprón C – PersonEntity: Name: NameFull: Fernández-Chacón M – PersonEntity: Name: NameFull: Escacena-Izquierdo L – PersonEntity: Name: NameFull: Del Toro R – PersonEntity: Name: NameFull: Rojas-Torres M – PersonEntity: Name: NameFull: Durán-Ruiz MC – PersonEntity: Name: NameFull: Siegfried G – PersonEntity: Name: NameFull: Ordóñez-Fernández A – PersonEntity: Name: NameFull: Khatib AM – PersonEntity: Name: NameFull: Rosado JA – PersonEntity: Name: NameFull: Smani T IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1524-4636 Numbering: – Type: volume Value: 46 – Type: issue Value: 6 Titles: – TitleFull: Arteriosclerosis, thrombosis, and vascular biology Type: main |
| ResultId | 1 |
